AbbVie Inc. announced earnings results for the fourth quarter ended December 31, 2018. For the fourth quarter, the company announced sales was USD 8,305 million compared to USD 7,739 million a year ago. Operating loss was USD 2,441 million compared to operating Income of USD 1,782 million a year ago. Net loss was USD 1,826 million compared to net income of USD 52 million a year ago. Diluted loss per share was USD 1.23 compared to diluted earnings per share of USD 0.03 a year ago. For the full year, sales was USD 32,753 million compared to USD 28,216 million a year ago. Operating income was USD 6,383 million compared to USD 9,545 million a year ago. Net income was USD 5,687 million compared to USD 5,309 million a year ago. Diluted earnings per share was USD 3.66 compared to USD 3.3 a year ago.